Wright Medical (WMGI) PT Raised to $32 at RBC Capital

Go back to Wright Medical (WMGI) PT Raised to $32 at RBC Capital

Wright Medical Group N.V. Reports 2018 Second Quarter Financial Results

August 8, 2018 4:05 PM EDT

Second Quarter 2018 Net Sales of $205 Million

Second Quarter 2018 Net Loss From Continuing Operations of $91 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $26 Million

U.S. Upper Extremities Business Increased 22%, Led by Sales Growth of SIMPLICITI Shoulder System

U.S. Lower Extremities Business Growth Rate Accelerates to 9%; AUGMENT® Injectable Approved in U.S.

Company Increases 2018 Annual Guidance

AMSTERDAM, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) --... More